Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ)

CUSIP: 00973N102

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
53,401,149
Total 13F shares
506,064
Share change
-20,627,553
Total reported value
$2,329
Price per share
$0.00
Number of holders
6
Value change
-$1,774,940
Number of buys
1
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP 00973N102?
CUSIP 00973N102 identifies AKTSQ - Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKTSQ - Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
6%
3,225,431
$290,289 30 Sep 2024
13F
Taylor Frigon Capital Management LLC
13F
Company
4.8%
2,568,927
$229,919 30 Sep 2024
13F
SILVERBACK ASSET MANAGEMENT LLC
13F
Company
4.8%
2,537,400
$227,097 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
3.9%
2,095,467
$187,545 30 Sep 2024
13F
Senvest Management, LLC
13F
Company
2.8%
1,500,000
$134,250 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
2.3%
1,205,574
$107,899 30 Sep 2024
13F
PERKINS CAPITAL MANAGEMENT INC
13F
Company
2.2%
1,173,001
$104,984 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
1,086,182
$97,228 30 Sep 2024
13F
Sargent Investment Group, LLC
13F
Company
2%
1,073,800
$96,105 30 Sep 2024
13F
West Tower Group, LLC
13F
Company
1.3%
714,429
$63,941 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.1%
589,957
$52,801 30 Sep 2024
13F
FRG Family Wealth Advisors LLC
13F
Company
0.65%
346,697
$31,029 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.5%
264,796
$23,699 30 Sep 2024
13F
Creative Planning
13F
Company
0.46%
243,741
$21,815 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.45%
242,267
$21,683 30 Sep 2024
13F
Ancora Advisors LLC
13F
Company
0.44%
235,804
$21,104 30 Sep 2024
13F
MISSION WEALTH MANAGEMENT, LP
13F
Company
0.42%
224,719
$20,113 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.4%
215,655
$19,301 30 Sep 2024
13F
TOWNSQUARE CAPITAL LLC
13F
Company
0.23%
122,485
$10,962 30 Sep 2024
13F
Gibbs Wealth Management
13F
Company
0.23%
122,467
$10,961 30 Sep 2024
13F
MARATHON CAPITAL MANAGEMENT
13F
Company
0.19%
102,100
$9,138 30 Sep 2024
13F
XTX Topco Ltd
13F
Company
0.19%
101,985
$9,128 30 Sep 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.19%
101,886
$9,119 30 Sep 2024
13F
Ethic Inc.
13F
Company
0.03%
14,935
$8,828 30 Sep 2024
13F
Adalta Capital Management LLC
13F
Company
0.17%
90,000
$8,055 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.17%
89,088
$7,973 30 Sep 2024
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.14%
76,540
$6,850 30 Sep 2024
13F
Baader Bank Aktiengesellschaft
13F
Company
0.14%
74,717
$4,791 30 Sep 2024
13F
RS CRUM INC.
13F
Company
0.1%
52,075
$4,661 30 Sep 2024
13F
Allworth Financial LP
13F
Company
0.09%
50,000
$4,475 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.08%
42,754
$3,826 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.08%
40,347
$3,611 30 Sep 2024
13F
LPL Financial LLC
13F
Company
0.07%
37,505
$3,357 30 Sep 2024
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.07%
35,800
$3,204 30 Sep 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.06%
34,564
$3,111 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
33,929
$3,020 30 Sep 2024
13F
American Capital Advisory, LLC
13F
Company
0.06%
33,630
$3,010 30 Sep 2024
13F
HBK Sorce Advisory LLC
13F
Company
0.06%
32,360
$2,897 30 Sep 2024
13F
WR Wealth Planners, LLC
13F
Company
0.06%
32,100
$2,873 30 Sep 2024
13F
DLK Investment Management, LLC
13F
Company
0.05%
28,500
$2,551 30 Sep 2024
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.05%
28,332
$2,536 30 Sep 2024
13F
Vanguard Personalized Indexing Management, LLC
13F
Company
0.05%
28,288
$2,532 30 Sep 2024
13F
StoneX Group Inc.
13F
Company
0.05%
28,276
$2,531 30 Sep 2024
13F
Kohmann Bosshard Financial Services, LLC
13F
Company
0.05%
27,756
$2,484 30 Sep 2024
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.04%
23,636
$2,000 30 Sep 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.03%
18,350
$2,000 30 Sep 2024
13F
Texas Yale Capital Corp.
13F
Company
0.04%
20,000
$1,790 30 Sep 2024
13F
Sweet Financial Partners, LLC
13F
Company
0.04%
19,226
$1,721 30 Sep 2024
13F
Cetera Investment Advisers
13F
Company
0.03%
17,547
$1,570 30 Sep 2024
13F
Dynamic Advisor Solutions LLC
13F
Company
0.03%
15,000
$1,343 30 Sep 2024
13F

Institutional Holders of Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ) as of Q4 2024

As of 31 Dec 2024, Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 506,064 shares. The largest 6 holders included XTX Topco Ltd, PERKINS CAPITAL MANAGEMENT INC, Kohmann Bosshard Financial Services, LLC, Topsail Wealth Management, LLC, Chicago Capital, LLC, and Kera Capital Partners, Inc.. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
74
Q4 2024 holders
6
Holder diff
-68
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .